ARQL

Arqule, Inc.

A biopharmaceutical company in Massachusetts that made targeted small-molecule cancer drugs, especially kinase inhibitors. Founded in 1993, it ran automated array-based chemistry to help big drug companies test compounds before shifting to develop its own therapies. Its name blends "array" and "quantitative" chemistry, and Merck bought the firm in 2020.